Back to NBIX
Daiwa Securities Group Inc. → NBIX
Daiwa Securities Group Inc. NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
9
Latest value
$2.9M
Q3 2026
Peak value
$3.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.2M |
| Q4 2025 | $1.2M |
| Q4 2025 | $1.2M |
| Q1 2026 | $1.2M |
| Q1 2026 | $1.8M |
| Q2 2026 | $1.5M |
| Q2 2026 | $3.1M |
| Q3 2026 | $1.3M |
| Q3 2026 | $2.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.9M | 20.6K | — | — |
| Q3 2026 | $1.3M | 9.3K | — | — |
| Q2 2026 | $3.1M | 18.4K | — | — |
| Q2 2026 | $1.5M | 9.0K | — | — |
| Q1 2026 | $1.8M | 13.6K | — | — |
| Q1 2026 | $1.2M | 8.9K | — | — |
| Q4 2025 | $1.2M | 8.2K | — | — |
| Q4 2025 | $1.2M | 8.7K | — | — |
| Q3 2025 | $1.2M | 8.7K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M